Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Drugs Made In America Acquisition Corp. Ordinary Shares
Market Cap
$264.62M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.32M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.30M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.73M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.51M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$260.97M
EBITDA Margin
-61.02%
TTM Avg
-27.35%
3Y Avg
-27.35%
5Y Avg
-27.35%
Market Cap
$270.60M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) | $264.62M | N/A | N/A | N/A | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.32M | N/A | N/A | N/A | N/A |
| Cantor Equity Partners V, Inc. Class A Ordinary Shares (CEPV)vs › | $262.30M | N/A | N/A | N/A | N/A |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A | N/A | N/A | N/A |
| Art Technology Acquisition Corp. (ARTC)vs › | $261.51M | N/A | N/A | N/A | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.19M | N/A | N/A | N/A | N/A |
| FACT II Acquisition Corp (FACT)vs › | $260.97M | -61.02% | -27.35% | -27.35% | -27.35% |
| Cartesian Growth Corp. Iv (CGCF)vs › | $269.77M | N/A | N/A | N/A | N/A |
| Freedom Metals Acquisition Corp. (FDMM)vs › | $270.60M | N/A | N/A | N/A | N/A |
| First National Corporation (FXNC)vs › | $270.87M | 23.59% | 17.71% | 22.98% | 25.64% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute